The efficacy of transcatheter mitral edge-to-edge repair (M-TEER) has been demonstrated in patients with severe secondary mitral regurgitation (MR). In clinical practice, some patients with moderate MR on transthoracic echocardiography (TTE) are considered to have clinically severe MR based on their clinical cour...
A. Sugiura, M. Yamamoto, S. Kubo et al.· European Heart Journal· 0 citations
BACKGROUND
Pulmonary hypertension (PH) is common in patients undergoing mitral valve transcatheter edge-to-edge repair (M-TEER), but the prognostic significance of periprocedural PH changes remains uncertain.
OBJECTIVES
This study sought to evaluate the association between periprocedural PH patterns and clinical outc...
J. Miyamoto, Yohei Ohno, S. Noda et al.· JACC: Cardiovascular Interve...· 1 citation
BACKGROUND
Acute or advanced valve syndrome (AVS), originally proposed in aortic stenosis to describe rapid clinical deterioration, has not been evaluated in mitral regurgitation (MR).
OBJECTIVES
This study sought to investigate the prognostic impact of AVS in patients with primary MR undergoing mitral transcatheter...
D. Miyahara, Izumo Masaki, S. Kuwata et al.· JACC: Asia· 1 citation
Current guidelines offer limited guidance on the optimal timing of mitral transcatheter edge-to-edge repair (M-TEER) in degenerative mitral regurgitation (DMR). We evaluated whether the interval between diagnosis of DMR with heart failure (HF) and M-TEER was associated with clinical outcomes. We analyzed 1,061 patients...
T. Shimura, M. Yamamoto, I. Kawamura et al.· American Journal of Cardiolo...· 0 citations
In patients with ventricular functional MR and LVEF <20%, M-TEER was feasible and associated with meaningful symptomatic improvement without excess risk of death or HF hospitalization, although CV mortality remained higher, likely reflecting advanced myocardial disease.
We aimed to investigate association of three DanGer Shock trial criteria [systolic blood pressure [SBP] < 100 mmHg, lactate ≥ 2.5 mmol/L, and left ventricular ejection fraction (LVEF) < 45%] on clinical outcomes among patients with ST-elevation myocardial infarction (STEMI) in Japan and evaluate whether these criteria...
Narumi Irie, Y. Sawayama, Mikitaka Fujita et al.· Heart and Vessels· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.